ad image

Outsourcing

1 / 8
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
Outsourced Manufacturing

A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing

April Stanley, MS MBA

Nice Insight

PAO-03-24-NI-02Mar 27, 2024
Maximizing Outsourcing Benefits for Virtual Pharma Companies
CDMO

Maximizing Outsourcing Benefits for Virtual Pharma Companies

William Kazimier

Tedor Pharma Services

PAO-09-23-CL-08Jan 11, 2024
Biologics Outsourcing: Decision Drivers and Key Considerations
Biomanufacturing

Biologics Outsourcing: Decision Drivers and Key Considerations

Scorpius BioManufacturing

PAO-04-23-CL-01Apr 18, 2023
Supporting Drug Development – Increasing Probability of Success
Consulting

Supporting Drug Development – Increasing Probability of Success

Nick Davies; Beth Lindsey; Ian Smart

Verta Life Sciences

PAO-03-23-CL-04Mar 24, 2023
Streamlining Highly Potent Drug Commercialization
High Potency

Streamlining Highly Potent Drug Commercialization

Norbert Straub; Uwe Korn; Robert Klehr

Fareva

PAO-04-21-CL-04Apr 19, 2021
Current Trends & Future Prospects in Outsourced Pharmaceutical Manufacturing
Outsourcing

Current Trends & Future Prospects in Outsourced Pharmaceutical Manufacturing

Achim Newrzella, Ph.D.

Results Healthcare

PAP-Q1-20-CL-027Mar 19, 2020
Customer Engagement and Information Sharing are Essential for Success in Orphan Drug Outsourcing
Orphan Drugs

Customer Engagement and Information Sharing are Essential for Success in Orphan Drug Outsourcing

Marga Viñes

Grifols

PAP-Q3-19-CL-013Oct 29, 2019
Integrated Outsourcing from RSMs to APIs
Regulatory Starting Materials (RSMs)

Integrated Outsourcing from RSMs to APIs

Scott Martin; Randall Andrews

Albemarle Fine Chemistry Services

PAP-Q2-2019-CL-004May 24, 2019
Aligning the Outsourcing Relationship
Outsourcing

Aligning the Outsourcing Relationship

Servier

PAP-Q1-2019-CL-006Apr 12, 2019
Supporting Patient-Centric Clinical Trials from Point-of-Origin through the Last Mile
Clinical Trials

Supporting Patient-Centric Clinical Trials from Point-of-Origin through the Last Mile

Wes Wheeler

Marken

PAP-Q2-18-CL-002May 29, 2018
State-of-the-Art Biologics Manufacturing in an Unexpected Location
GMP

State-of-the-Art Biologics Manufacturing in an Unexpected Location

Vladas Algirdas Bumelis

Northway Biotechpharma

PAP-Q2-18-CL-010May 29, 2018
Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing
Cell and Gene Therapy

Overcoming Raw Material and Supply Chain Challenges in Viral Vector Manufacturing

Richard Snyder, Ph.D.; Christopher K. Murphy; Susan D'Costa, Ph.D.; Cameron Jones

Thermo Fisher Scientific

PAP-Q2-18-CL-011May 29, 2018
Strengthening the Outsource Service Offering through Integration
Integration

Strengthening the Outsource Service Offering through Integration

Luigi Trussardo

Olon

PAP-Q2-18-CL-013May 29, 2018
Achieving Controlled Nucleation During Aseptic Lyophilization
Controlled Nucleation

Achieving Controlled Nucleation During Aseptic Lyophilization

Robert Darrington

SP Industries

PAP-Q2-18-CL-018May 29, 2018
Pharma Contract Services Consolidation Wave Continues
Nice Insight Overview

Pharma Contract Services Consolidation Wave Continues

Nigel Walker; Ariette van Strien

Nice Insight

PAP-Q3-17-NO-001Sep 15, 2017
Mergers & Acquisitions: Combining Market Segments
In Conversation

Mergers & Acquisitions: Combining Market Segments

Guy Tiene; Gary Lord; Dago Caceres

Nice Insight

PAP-Q3-17-IC-001Sep 15, 2017
Building the Foundation of Japan’s Premier CDMO
Global Partners

Building the Foundation of Japan’s Premier CDMO

Toshio Yoshioka; Tetsuo Okada

PAP-Q3-17-CL-006Sep 15, 2017
Q: How important are international partnerships (with sponsor firms, service providers, engineering firms, equipment vendors, raw material suppliers, etc.) to your success?
Roundtable

Q: How important are international partnerships (with sponsor firms, service providers, engineering firms, equipment vendors, raw material suppliers, etc.) to your success?

Pharma's Almanac

PAP-Q3-17-RT-001Sep 15, 2017
Biologics: Driving Force in Pharma
Biologics

Biologics: Driving Force in Pharma

Nigel Walker

Nice Insight

PAP-Q2-17-NO-001Jun 05, 2017
Hiring Top Talent in Pharma

Hiring Top Talent in Pharma

Nice Insight

PTV-M11-16-AP-009Apr 06, 2017
1 / 8